ELEVATION ONCOLOGY INC (ELEV) Institutional Ownership
None of the superinvestors we track currently report ELEVATION ONCOLOGY INC (ELEV) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in ELEVATION ONCOLOGY INC (ELEV), this page will show institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q2 2025 | 1 | $60,876 | 165,829 |
| Q1 2025 | 1 | $167,715 | 647,300 |
| Q4 2024 | 1 | $902,022 | 1,603,309 |
| Q3 2024 | 1 | $1,071,411 | 1,785,982 |
| Q4 2023 | 1 | $237 | 441,490 |
| Q2 2023 | 1 | $26 | 16,800 |
| Q1 2023 | 1 | $98 | 51,500 |
| Q4 2022 | 1 | $190 | 199,900 |
| Q3 2022 | 1 | $326 | 288,657 |
| Q2 2022 | 1 | $362 | 258,400 |
| Q1 2022 | 1 | $64 | 25,400 |
| Q4 2021 | 1 | $100 | 16,600 |
Related ELEV Institutional Insights:
- ELEV Institutional Ownership & Insiders Activity
- ELEV Institutional Ownership & 13F Activity
- ELEV Top Institutional Shareholders
- ELEV Institutional Buying Activity
- ELEV Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- ELEV Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings